- Home
- CIA vs ARMP Comparison
CIA vs ARMP Comparison
Compare CIA & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIA | ARMP |
|---|---|---|
| Founded | 1969 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.0M | 296.7M |
| IPO Year | 1995 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CIA | ARMP |
|---|---|---|
| Price | $5.12 | $11.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 77.1K | 45.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.40 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $245,001,000.00 | N/A |
| Revenue This Year | $3.65 | N/A |
| Revenue Next Year | $3.51 | N/A |
| P/E Ratio | $28.23 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.90 | $0.90 |
| 52 Week High | $6.40 | $13.75 |
Technical Indicators
Market Signals| Indicator | CIA | ARMP |
|---|---|---|
| Relative Strength Index (RSI) | 37.43 | 61.14 |
| Support Level | $5.04 | $5.14 |
| Resistance Level | $5.44 | $12.23 |
| Average True Range (ATR) | 0.37 | 1.02 |
| MACD | -0.09 | 0.07 |
| Stochastic Oscillator | 19.01 | 62.86 |
Price Performance
Historical ComparisonAbout CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.